Showing results (11-20 of 158) with videos related to
Sort By:
Pageof 16
Current Opinion in Nephrology and Hypertension|May 1, 1996
Immunomodulatory function of major histocompatibility complex-derived peptidesB Murphy, M H SayeghClinical and Experimental Rheumatology|November 21, 2007
The evolution of the immunobiology of co-stimulatory pathways: clinical implicationsS Trikudanathan, M H SayeghExpert Opinion on Investigational Drugs|November 4, 2000
CTLA4-Ig: a novel immunosuppressive agentN Najafian, M H SayeghThe Journal of Clinical Investigation|April 4, 2001
Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivoA M Waaga, M Gasser, J E Kist-van Holthe, et al.Current Opinion in Immunology|November 22, 1997
Peptide-mediated immunosuppressionC C Magee, M H SayeghInternational Reviews of Immunology|January 1, 1996
Role of indirect allorecognition in allograft rejectionM H Sayegh, C B CarpenterKidney International. Supplement|January 1, 1996
Novel immunotherapeutic strategies using MHC derived peptidesM H Sayegh, A M KrenskyJournal of the American Society of Nephrology : JASN|October 1, 1995
T cell costimulatory pathways: promising novel targets for immunosuppression and tolerance inductionM H Sayegh, L A TurkaTransplantation Proceedings|August 5, 2009
Regulatory T cells in transplantation: what we know and what we do not knowM Y Yeung, M H SayeghTransplantation Proceedings|March 26, 2004
The antagonism of calcineurin inhibitors and costimulatory blockers: fact or fiction?A Izawa, M H Sayegh, A ChandrakerPageof 16